Clinical trial

GISSOC II: Sirolimus Eluting Stent Versus Bare Metal Stent in Chronic Total…

NCT00220558 · Società Italiana di Cardiologia Invasiva, Other · Unknown status

Key facts

NCT number NCT00220558
Title GISSOC II: Sirolimus Eluting Stent Versus Bare Metal Stent in Chronic Total Coronary Occlusions
Official title A Randomized Comparison of Sirolimus Eluting Stent Versus Bare Metal Stent in Chronic Total Coronary Occlusions: The Gruppo Italiano di Studio Sullo Stent Nelle Occlusioni Coronariche. The GISSOC II Study.
Lead sponsor Società Italiana di Cardiologia Invasiva, Other
Collaborators Cordis Italy a division of Johnson & Johnson Medical SpA
Status Unknown status
Phase Phase 4
Study type Interventional
Conditions Coronary Artery Disease
Intervention type Device
Interventions Coronary placement of bare metal stent vs. drug eluting stent
Enrollment 150
Start date May 1, 2005
Primary completion Oct 1, 2007
Completion Feb 1, 2010
First posted Sep 22, 2005
Last update posted Dec 4, 2009
Countries Italy

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies